All data are based on the daily closing price as of November 11, 2026
t

Tsumura &

4540.TSE
24.16 USD
-0.52
-2.11%

Overview

Last close
24.16 usd
Market cap
1.80B usd
52 week high
27.04 usd
52 week low
22.38 usd
Target price
26.86 usd

Valuation

P/E
9.1648
Forward P/E
11.4811
Price/Sales
1.4106
Price/Book Value
0.8552
Enterprise Value
2.17B usd
EV/Revenue
1.669
EV/EBITDA
5.4616

Key financials

Revenue TTM
1.30B usd
Gross Profit TTM
608.38M usd
EBITDA TTM
324.02M usd
Earnings per Share
2.68 usd
Dividend
0.5 usd
Total assets
4.19B usd
Net debt
360.57M usd

About

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. In addition, it produces and sells alcoholic beverages and food products. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.
  • Symbol
    4540.TSE
  • Exchange
    TSE
  • Isin
    JP3535800001
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Terukazu Kato
  • Headquarter
    Tokyo
  • Web site
    https://www.tsumura.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top